Biologic API CDMO Benchmarking (11th Ed.)

Demand for biologic API capabilities continues to grow, with sponsors placing greater scrutiny on CDMOs and further intensifying competition among providers. ISR’s Biologic API CDMO Benchmarking examines how sponsors assess providers, which attributes shape selection decisions, and where CDMOs are meeting or missing expectations. The study delivers comparative performance insights and quality benchmarks to help organizations understand their competitive standing and sharpen their positioning. These insights support more targeted, evidence‑based messaging in a competitive biologic drug substance market.

What you will learn:

Outsourcing Practices

• Proportion of manufacturing activities outsourced
• Main driver in outsourcing
• Preferred provider usage and management

CDMO Selection Drivers

• Top CDMO selection attributes
• Attributes growing in importance

CDMO Perceptions & Interactions

• CDMO brand familiarity and usage
• Leadership, preference, and proposal volume
• CDMO cost perceptions

CDMO Performance & Competitive Landscape

• How CDMOs measure up to sponsor expectations
• Competitive position across providers

Company Service Quality Profiles

• 20+ CDMO profiles
• Customer feedback on 23 performance metrics
• Overall Satisfaction, Likelihood to Use Again, and Willingness to Recommend

Included Providers:

Companies listed in bold print have a Company Service Quality Profile page detailing company performance based on user ratings (currently using or have used in the past 18 months).

• AbbVie Contract Manufacturing
• Abzena
• AGC Biologics
• Ajinomoto Bio-Pharma Services
• Avid Bioservices
• Axplora
• Bionova
• Boehringer Ingelheim BioXcellence
• Bora Pharmaceuticals
• Catalent
• Celonic
• Curia
• Cytovance Biologics
• Fujifilm Biotechnologies
• Genscript ProBio
• GSK Contract Manufacturing
• Hetero Biopharma
• IDT Biologika
• Just – Evotec Biologics
• KBI Biopharma
• Lonza
• MilliporeSigma
• Novartis CDMO (Global Biotech Cooperations)
• Olon
• Patheon, by Thermo Fisher Scientific
• Pfizer CentreOne
• Rentschler
• Resilience
• Samsung Biologics
• Sandoz
• Scorpius Biomanufacturing
• Syngene
• Wockhardt
• WuXi Biologics

Respondents were required to pass several screening criteria to qualify and participate in this survey:

• Must work at a biopharmaceutical company
• Must have responsibilities in the following categories: executive management, R&D management, clinical operations, clinical trial manufacturing, commercial manufacturing, outsourcing/purchasing management, QA/QC, supply chain or validation
• Must have been involved in outsourced biologic drug substance manufacturing within the past 18 months